Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

No Comments

Positive trial results of Janssen's sabeluzole in obstructive sleep apnea patients

July 19, 1996

No Comments

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

July 19, 1996

No Comments

BTG-2403: representative opioid analgesic

July 19, 1996

No Comments

Glaxo Wellcome's Ultiva receives FDA approval

July 19, 1996

No Comments

NOS inhibitors from Merck & Co.

July 12, 1996

No Comments

TNF research findings

July 12, 1996

No Comments

Muscarinic receptor ligand selected for further study

July 12, 1996

No Comments

First demonstration of cellular mechanism of human oral tolerance

July 12, 1996

No Comments

First approval of SmithKline Beecham's ReQuip in U.K.

July 12, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

5-HT1A receptor-selective agents from American Home Products

Positive trial results of Janssen's sabeluzole in obstructive sleep apnea patients

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

BTG-2403: representative opioid analgesic

Glaxo Wellcome's Ultiva receives FDA approval

NOS inhibitors from Merck & Co.

TNF research findings

Muscarinic receptor ligand selected for further study

First demonstration of cellular mechanism of human oral tolerance

First approval of SmithKline Beecham's ReQuip in U.K.

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

Neurology/psychiatric RSS

Neurology/psychiatric
RSS